The Trump administration has revised the terms of a pilot effort that allows some drugmakers to offer rebates to certain ...
Allison covers what hot startups are getting up to, and who’s financing them. She is also co-host of the weekly biotech podcast, “The Readout Loud.” You can reach Allison on Signal at AllisonDeAngelis ...
Ten years ago, the World Health Organization added mycetoma to its official list of neglected tropical diseases. Caused by ...
A group of outside experts convened by the Food and Drug Administration on Thursday voted in favor of Replimune’s experimental treatment for advanced melanoma. In a 10-3 vote, t ...
An FDA advisory panel recommended use of an experimental Replimune treatment for advanced melanoma that the agency has rejected twice ...
Federal judge denied 26 states’ request to postpone the implementation of Medicaid work requirements announced in June.
UCSD researchers have spent years building trust in communities of unhoused people who use drugs in San Diego and across the border in Tijuana. Since spring, some 10% of their research participants ...
The ADA is no longer what we’d call a profile in courage,” write Adam Marcus and Ivan Oransky of Retraction Watch.
Students working in fields eligible for NSF funding will be able to participate, including chemistry, engineering, and basic ...
The appropriate counter to Covid revisionism is careful, rigorous, and honest assessment of the U.S. response.” ...
Patients, advocates, and experts fear the difficulty in documenting a frailty exemption to Medicaid work requirements will ...
Too often, regulatory tools authorized to speed patient access to breakthrough treatments are being used in ways that even prevent approval,” writes Kat Bryant Knudson.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results